Laval, Québec – Solstar Pharma continues to make great strides as a leader in nucleic acid medicine. With a management team of biopharmaceutical experts with considerable expertise in drug discovery, development, and commercialization, Solstar Pharma is contributing to broaden the boundaries of science.
Consequently, Solstar Pharma has appointed Professor Nahum Sonenberg, PhD, to its scientific advisory board. Professor Sonenberg, who has extensive experience in RNA and cancer research, will guide Solstar Pharma’s projects and overall research and development strategy.
“We are extremely proud to welcome Prof. Sonenberg to our Scientific Advisory Board. His many discoveries and contributions to biomedical research have significantly advanced medicine. Having someone of his stature is an incredible complement to our company” said Tom Rossi, President and CEO of Solstar Pharma.
To learn more about Solstar Pharma’s scientific advisors, please go to: https://solstarpharma.com/scientific-advisors
Prof. Nahum Sonenberg, PhD